Susan L Mooberry

12PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesPredictive and prognostic markersMolecular targetsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 11, 2022
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models.

Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson

|Jan 11, 2022
Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidines as Microtubule Targeting Agents.

Farhana Islam, Arpit Doshi, Andrew J Robles

|Dec 24, 2021
Altertoxin II, a Highly Effective and Specific Compound against Ewing Sarcoma.

Andrew J Robles, Wentao Dai, Saikat Haldar

|Jul 02, 2021
Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells.

Petra J Pederson, Huiyun Liang, Daria Filonov

|Jul 02, 2021
Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential.

Charles S Fermaintt, Thilini Peramuna, Shengxin Cai

|Nov 23, 2020
An Integrated Strategy for the Detection, Dereplication, and Identification of DNA-Binding Biomolecules from Complex Natural Product Mixtures.

Hongyan Ma, Huiyun Liang, Shengxin Cai

Pageof 2

Frequent Collaborators

7 joint publications

April L Risinger

4 joint publications

Robert H Cichewicz

4 joint publications

Barry R O'Keefe

2 joint publications

Corena V Grant